2016-03-15T00:00:00.000-04:00
email newsletter,0.352663
target price points,0.583126
price target,0.393821
research analysts,0.395785
Tekla Capital Management,0.00479692
stock,0.378824
consensus price target,0.487125
genome engineering,0.447577
Zacks Investment Research‘s,0.583126
email address,0.323665
related companies,0.352664
InvestorPlace Broker Center,0.555736
Management LLC,0.00479692
high fees,-0.735674
research report,-0.327558
Cellectis SA,-0.0529979
gene-editing company,-0.317358
Zacks Investment Research,0.223481
personal trading style,0.598412
latest news,0.323665
Cellectis SA Daily,-0.272427
Capital Management LLC,0.00479692
buy rating,0.395785
genome engineering technologies,0.447577
Market Beat.com reports,-0.212645
shares,-0.036018
Deoxyribonucleic Acid,0.480604
concise daily summary,0.323665
Artal Group S.A.,-0.252686
previous close,0.583126
stock broker,0.245696
company,-0.0836618
consensus rating,0.500502
rating,0.10202
potential upside,0.583126
gene excision,-0.237635
quarter,-0.0070962
